Annual CFO
$1.07 B
+$516.91 M+93.21%
December 31, 2023
Summary
- As of February 12, 2025, GMAB annual cash flow from operations is $1.07 billion, with the most recent change of +$516.91 million (+93.21%) on December 31, 2023.
- During the last 3 years, GMAB annual CFO has risen by +$85.81 million (+8.71%).
- GMAB annual CFO is now at all-time high.
Performance
GMAB Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
$308.77 M
+$92.36 M+42.68%
September 1, 2024
Summary
- As of February 12, 2025, GMAB quarterly cash flow from operations is $308.77 million, with the most recent change of +$92.36 million (+42.68%) on September 1, 2024.
- Over the past year, GMAB quarterly CFO has increased by +$11.74 million (+3.95%).
- GMAB quarterly CFO is now -62.25% below its all-time high of $817.99 million, reached on September 30, 2020.
Performance
GMAB Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
$983.47 M
+$11.74 M+1.21%
September 1, 2024
Summary
- As of February 12, 2025, GMAB TTM cash flow from operations is $983.47 million, with the most recent change of +$11.74 million (+1.21%) on September 1, 2024.
- Over the past year, GMAB TTM CFO has increased by +$71.07 million (+7.79%).
- GMAB TTM CFO is now -15.46% below its all-time high of $1.16 billion, reached on September 30, 2020.
Performance
GMAB TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
GMAB Cash From Operations Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +93.2% | +4.0% | +7.8% |
3 y3 years | +8.7% | -33.8% | +5.5% |
5 y5 years | +566.4% | -33.8% | +5.5% |
GMAB Cash From Operations Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +202.2% | -33.8% | +681.7% | -8.2% | +291.9% |
5 y | 5-year | at high | +438.9% | -62.3% | +305.5% | -15.5% | +497.0% |
alltime | all time | at high | +1104.3% | -62.3% | +305.5% | -15.5% | +935.6% |
Genmab A/S Cash From Operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $308.77 M(+42.7%) | $983.47 M(+1.2%) |
Jun 2024 | - | $216.41 M(-1.8%) | $971.73 M(+17.7%) |
Mar 2024 | - | $220.38 M(-7.4%) | $825.32 M(-23.0%) |
Dec 2023 | $1.07 B(+93.2%) | $237.91 M(-19.9%) | $1.07 B(+17.4%) |
Sep 2023 | - | $297.03 M(+324.3%) | $912.39 M(+4.9%) |
Jun 2023 | - | $70.00 M(-85.0%) | $869.77 M(-6.7%) |
Mar 2023 | - | $466.53 M(+491.8%) | $932.55 M(+68.2%) |
Dec 2022 | $554.57 M(+56.4%) | $78.83 M(-69.0%) | $554.57 M(+7.6%) |
Sep 2022 | - | $254.41 M(+91.6%) | $515.24 M(+57.9%) |
Jun 2022 | - | $132.78 M(+49.9%) | $326.27 M(+30.0%) |
Mar 2022 | - | $88.55 M(+124.2%) | $250.97 M(-29.2%) |
Dec 2021 | $354.52 M(-64.0%) | $39.50 M(-39.6%) | $354.52 M(+115.2%) |
Sep 2021 | - | $65.44 M(+13.9%) | $164.75 M(-82.0%) |
Jun 2021 | - | $57.48 M(-70.1%) | $917.29 M(+2.5%) |
Mar 2021 | - | $192.10 M(-227.8%) | $895.20 M(-9.2%) |
Dec 2020 | $985.67 M(+395.7%) | -$150.27 M(-118.4%) | $985.67 M(-15.3%) |
Sep 2020 | - | $817.99 M(+2211.4%) | $1.16 B(+197.1%) |
Jun 2020 | - | $35.39 M(-87.5%) | $391.61 M(+2.3%) |
Mar 2020 | - | $282.57 M(+932.7%) | $382.77 M(+92.5%) |
Dec 2019 | $198.82 M(+23.7%) | $27.36 M(-40.9%) | $198.82 M(-3.4%) |
Sep 2019 | - | $46.29 M(+74.3%) | $205.83 M(+8.3%) |
Jun 2019 | - | $26.55 M(-73.1%) | $189.98 M(+3.9%) |
Mar 2019 | - | $98.62 M(+187.0%) | $182.84 M(+13.7%) |
Dec 2018 | $160.78 M(-33.5%) | $34.36 M(+12.9%) | $160.78 M(+2.5%) |
Sep 2018 | - | $30.45 M(+56.9%) | $156.85 M(+7.3%) |
Jun 2018 | - | $19.41 M(-74.6%) | $146.22 M(-30.6%) |
Mar 2018 | - | $76.56 M(+151.6%) | $210.71 M(-12.9%) |
Dec 2017 | $241.87 M(+396.5%) | $30.43 M(+53.6%) | $241.87 M(+21.4%) |
Sep 2017 | - | $19.82 M(-76.4%) | $199.27 M(-5.0%) |
Jun 2017 | - | $83.90 M(-22.1%) | $209.77 M(+33.0%) |
Mar 2017 | - | $107.72 M(-985.4%) | $157.71 M(+223.8%) |
Dec 2016 | $48.71 M(+5.1%) | -$12.17 M(-140.1%) | $48.71 M(-50.5%) |
Sep 2016 | - | $30.32 M(-4.8%) | $98.31 M(+11.1%) |
Jun 2016 | - | $31.84 M(-2593.4%) | $88.51 M(+65.6%) |
Mar 2016 | - | -$1.28 M(-103.4%) | $53.45 M(+15.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2015 | $46.34 M(+95.8%) | $37.44 M(+82.5%) | $46.34 M(+330.9%) |
Sep 2015 | - | $20.51 M(-736.4%) | $10.75 M(+72.4%) |
Jun 2015 | - | -$3.22 M(-61.6%) | $6.24 M(-67.2%) |
Mar 2015 | - | -$8.39 M(-552.9%) | $19.01 M(-19.7%) |
Dec 2014 | $23.66 M(-203.8%) | $1.85 M(-88.4%) | $23.66 M(+21.4%) |
Sep 2014 | - | $16.00 M(+67.6%) | $19.49 M(-455.5%) |
Jun 2014 | - | $9.54 M(-355.7%) | -$5.48 M(-71.7%) |
Mar 2014 | - | -$3.73 M(+60.7%) | -$19.35 M(-15.1%) |
Dec 2013 | -$22.79 M(-286.1%) | -$2.32 M(-74.1%) | -$22.79 M(-12.0%) |
Sep 2013 | - | -$8.97 M(+107.6%) | -$25.90 M(-199.6%) |
Jun 2013 | - | -$4.32 M(-39.8%) | $26.00 M(+51.6%) |
Mar 2013 | - | -$7.18 M(+32.1%) | $17.16 M(+40.1%) |
Dec 2012 | $12.25 M(-115.0%) | -$5.43 M(-112.7%) | $12.25 M(-497.5%) |
Sep 2012 | - | $42.93 M(-426.1%) | -$3.08 M(-95.3%) |
Jun 2012 | - | -$13.17 M(+8.9%) | -$65.35 M(-18.8%) |
Mar 2012 | - | -$12.09 M(-41.8%) | -$80.45 M(-1.5%) |
Dec 2011 | -$81.68 M(-271.1%) | -$20.76 M(+7.3%) | -$81.68 M(-3.0%) |
Sep 2011 | - | -$19.34 M(-31.6%) | -$84.23 M(-223.3%) |
Jun 2011 | - | -$28.27 M(+112.4%) | $68.34 M(-8.9%) |
Mar 2011 | - | -$13.31 M(-42.9%) | $75.01 M(+57.1%) |
Dec 2010 | $47.74 M(-144.7%) | -$23.32 M(-117.5%) | $47.74 M(-15.0%) |
Sep 2010 | - | $133.23 M(-717.0%) | $56.15 M(-147.7%) |
Jun 2010 | - | -$21.59 M(-46.8%) | -$117.69 M(+3.1%) |
Mar 2010 | - | -$40.58 M(+172.2%) | -$114.17 M(+7.0%) |
Dec 2009 | -$106.69 M(+5.5%) | -$14.91 M(-63.3%) | -$106.69 M(+16.2%) |
Sep 2009 | - | -$40.61 M(+124.7%) | -$91.78 M(+79.4%) |
Jun 2009 | - | -$18.08 M(-45.4%) | -$51.17 M(+54.6%) |
Mar 2009 | - | -$33.09 M | -$33.09 M |
Dec 2008 | -$101.12 M(-208.7%) | - | - |
Dec 2007 | $93.03 M(-245.5%) | - | - |
Dec 2006 | -$63.94 M(+83.5%) | - | - |
Dec 2005 | -$34.85 M(-43.3%) | - | - |
Dec 2004 | -$61.50 M(+33.6%) | - | - |
Dec 2003 | -$46.03 M(+17.3%) | - | - |
Dec 2002 | -$39.23 M | - | - |
FAQ
- What is Genmab A/S annual cash flow from operations?
- What is the all time high annual CFO for Genmab A/S?
- What is Genmab A/S annual CFO year-on-year change?
- What is Genmab A/S quarterly cash flow from operations?
- What is the all time high quarterly CFO for Genmab A/S?
- What is Genmab A/S quarterly CFO year-on-year change?
- What is Genmab A/S TTM cash flow from operations?
- What is the all time high TTM CFO for Genmab A/S?
- What is Genmab A/S TTM CFO year-on-year change?
What is Genmab A/S annual cash flow from operations?
The current annual CFO of GMAB is $1.07 B
What is the all time high annual CFO for Genmab A/S?
Genmab A/S all-time high annual cash flow from operations is $1.07 B
What is Genmab A/S annual CFO year-on-year change?
Over the past year, GMAB annual cash flow from operations has changed by +$516.91 M (+93.21%)
What is Genmab A/S quarterly cash flow from operations?
The current quarterly CFO of GMAB is $308.77 M
What is the all time high quarterly CFO for Genmab A/S?
Genmab A/S all-time high quarterly cash flow from operations is $817.99 M
What is Genmab A/S quarterly CFO year-on-year change?
Over the past year, GMAB quarterly cash flow from operations has changed by +$11.74 M (+3.95%)
What is Genmab A/S TTM cash flow from operations?
The current TTM CFO of GMAB is $983.47 M
What is the all time high TTM CFO for Genmab A/S?
Genmab A/S all-time high TTM cash flow from operations is $1.16 B
What is Genmab A/S TTM CFO year-on-year change?
Over the past year, GMAB TTM cash flow from operations has changed by +$71.07 M (+7.79%)